High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for Microsatellite Stable (MSS) Colorectal Liver Metastases (CRLM)
Latest Information Update: 26 Sep 2023
At a glance
- Drugs Zimberelimab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms HaRyPOT
- 26 Sep 2023 New trial record